Laboratorios Richmond SACIF

Laboratorios Richmond SACIF Book Value per Share

The Book Value per Share of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is 796.24 ARS. In the previous year, Book Value per Share was 279.25 ARS — a change of 185.14% (higher).

Book Value per Share

796.24ARS

YoY

185.14%

Last updated:

Book Value per Share of Laboratorios Richmond SACIF is 2024 796.24 ARS. Book Value per Share of Laboratorios Richmond SACIF was 2023 279.25 ARS. It decreases by 185.14% higher compared to the previous year.

The Laboratorios Richmond SACIF Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2017
15.52 ARS
Jan 1, 2018
20.03 ARS
Jan 1, 2019
34.56 ARS
Jan 1, 2020
63.19 ARS
Jan 1, 2021
127.70 ARS
Jan 1, 2022
124.95 ARS
Jan 1, 2023
279.25 ARS
Jan 1, 2024
796.24 ARS
The Laboratorios Richmond SACIF Book Value per Share history
YEARBook Value per ShareYoY
796.24ARS+185.14%
279.25ARS+123.48%
124.95ARS-2.15%
127.70ARS+102.09%
63.19ARS+82.81%
34.56ARS+72.59%
20.03ARS+29.04%
15.52ARS+561.49%
2.35ARS+97.15%
1.19ARS+3.33%
1.15ARS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Book Value per Share of Laboratorios Richmond SACIF is 796.24 ARS in 2024.

Book Value per Share of Laboratorios Richmond SACIF changed from 279.25 ARS to 796.24 ARS, representing a 185.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF